Teva ADR: income appeared below forecasts, pribylya overtook expectations in Q1

To Add/clean TEVA of-2,19% from a portfolio to Add in the Position Add a Position list it is successfully added: %2B to Add other position to Close Investing.com - Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) issued on Wednesday the report with results in the first quarter which disappointed analysts. The indicator of the income exceeded forecasts. Company declared an earning per share of $0,40, the income made of $3,7B. The analysts interrogated by Investing.com, assumed in forecasts that the earning per share will make $0,55, and the total income will make of $3,61B Teva Pharmaceutical Industries Ltd ADR follows the general trend of companies sectors...